Renaissance Technologies’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $293K | Buy |
209,501
+151,901
| +264% | +$213K | ﹤0.01% | 3047 |
|
2025
Q1 | $92.7K | Sell |
57,600
-132,800
| -70% | -$214K | ﹤0.01% | 3209 |
|
2024
Q4 | $240K | Buy |
190,400
+63,400
| +50% | +$79.9K | ﹤0.01% | 3114 |
|
2024
Q3 | $239K | Buy |
127,000
+107,800
| +561% | +$203K | ﹤0.01% | 3065 |
|
2024
Q2 | $142K | Buy |
+19,200
| New | +$142K | ﹤0.01% | 3115 |
|
2023
Q3 | – | Sell |
-48,302
| Closed | -$358K | – | 3645 |
|
2023
Q2 | $358K | Sell |
48,302
-53,898
| -53% | -$399K | ﹤0.01% | 3048 |
|
2023
Q1 | $966K | Sell |
102,200
-57,400
| -36% | -$543K | ﹤0.01% | 2500 |
|
2022
Q4 | $1.7M | Buy |
159,600
+81,300
| +104% | +$866K | ﹤0.01% | 2179 |
|
2022
Q3 | $578K | Buy |
78,300
+20,600
| +36% | +$152K | ﹤0.01% | 2845 |
|
2022
Q2 | $278K | Buy |
+57,700
| New | +$278K | ﹤0.01% | 3500 |
|
2020
Q3 | – | Sell |
-120,212
| Closed | -$1.27M | – | 3363 |
|
2020
Q2 | $1.27M | Buy |
120,212
+80,664
| +204% | +$851K | ﹤0.01% | 2429 |
|
2020
Q1 | $230K | Buy |
39,548
+6,537
| +20% | +$38K | ﹤0.01% | 3066 |
|
2019
Q4 | $216K | Buy |
33,011
+16,325
| +98% | +$107K | ﹤0.01% | 3175 |
|
2019
Q3 | $115K | Buy |
16,686
+9,632
| +137% | +$66.4K | ﹤0.01% | 3249 |
|
2019
Q2 | $52K | Buy |
7,054
+2,409
| +52% | +$17.8K | ﹤0.01% | 3450 |
|
2019
Q1 | $67K | Buy |
4,645
+1,911
| +70% | +$27.6K | ﹤0.01% | 3342 |
|
2018
Q4 | $32K | Sell |
2,734
-11,385
| -81% | -$133K | ﹤0.01% | 3307 |
|
2018
Q3 | $314K | Buy |
14,119
+1,202
| +9% | +$26.7K | ﹤0.01% | 3003 |
|
2018
Q2 | $248K | Buy |
12,917
+11,974
| +1,270% | +$230K | ﹤0.01% | 3022 |
|
2018
Q1 | $10K | Buy |
+943
| New | +$10K | ﹤0.01% | 3336 |
|
2017
Q3 | – | Sell |
-382
| Closed | -$14K | – | 3195 |
|
2017
Q2 | $14K | Sell |
382
-2,729
| -88% | -$100K | ﹤0.01% | 3162 |
|
2017
Q1 | $141K | Sell |
3,111
-707
| -19% | -$32K | ﹤0.01% | 3040 |
|
2016
Q4 | $100K | Buy |
+3,818
| New | +$100K | ﹤0.01% | 3102 |
|
2015
Q2 | – | Sell |
-3,160
| Closed | -$234K | – | 3214 |
|
2015
Q1 | $234K | Buy |
+3,160
| New | +$234K | ﹤0.01% | 2833 |
|